Get the Stockscreener App
1.62
0.93%
0.01
22nd Century Group, Inc. stock is traded at $1.62, with a volume of 100.45K.
It is up +0.93% in the last 24 hours and down -31.14% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$1.61
Open:
$1.68
24h Volume:
100.45K
Relative Volume:
1.73
Market Cap:
$1.17M
Revenue:
$17.59M
Net Income/Loss:
$-13.12M
P/E Ratio:
-0.00752
EPS:
-215.5494
Net Cash Flow:
$-8.60M
1W Performance:
-4.97%
1M Performance:
-31.14%
6M Performance:
-92.53%
1Y Performance:
-87.25%
1-Day Range:
$1.53
$1.68
1-Week Range:
$1.53
$1.78
52-Week Range:
$1.53
$168.00
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
1.62 | 1.21M | 17.59M | -13.12M | -8.60M | -215.55 |
VRTX
Vertex Pharmaceuticals Inc
|
429.46 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
705.33 | 76.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
780.07 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.58 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
295.34 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership - The Manila Times
FDA-authorized low-nicotine cigarette maker plans wider 2026 rollout - Stock Titan
[DEF 14A] 22nd Century Group, Inc. Definitive Proxy Statement - Stock Titan
22nd Century Group's reduced nicotine bet falls flat with investors - MSN
22nd Century Appoints Robert Manfredonia as Executive Vice President of Sales and Marketing - TMX Newsfile
22nd Century Group (XXII) Signs Large New CMO Customer - TMX Newsfile
22nd Century Group Completes Sale of Hemp/Cannabis Franchise - TMX Newsfile
22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule - TMX Newsfile
22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction - TMX Newsfile
22nd Century Group Announces Partial Adjournment of Annual Meeting for Proposal 2, All Other Proposals Passed - TMX Newsfile
22nd Century Eliminates an Additional $2.3 Million of Debt - TMX Newsfile
22nd Century Announces Resignation of John Miller as President of Tobacco - TMX Newsfile
22nd Century Group Provides Update on Incident at Grass Valley Facility - TMX Newsfile
22nd Century Group Provides Update on Grass Valley Facility - TMX Newsfile
22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms - TMX Newsfile
22nd Century Announces New Greenbutts Manufacturing Agreement for Innovative Plant-Based, Biodegradable Cigarette Filters - TMX Newsfile
22nd Century Announces New Branded Products Order with Customer for Southeast Asia - TMX Newsfile
22nd Century Group Reports Second Quarter 2024 Financial Results - TMX Newsfile
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes - TMX Newsfile
22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume - TMX Newsfile
22nd Century Group to effect 1-for-15 reverse stock split for Nasdaq compliance - MSN
22nd Century (XXII) Partners with NC State for Tobacco Testing S - GuruFocus
Is 22nd (XXII) stock outperforming the market | 22nd Century Group Inc delivers 98.8% EPS beat vs consensus estimatesMargin Expansion - Cổng thông tin điện tử tỉnh Lào Cai
22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University - The Manila Times
Low-nicotine tobacco project pairs 22nd Century with NC State on yields - Stock Titan
XXII Q1'26 Earnings: revenue estimate is 4.61M USD - TradingView
XXII Technical Analysis | Trend, Signals & Chart Patterns | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22nd Century Group misses Q4 top-line estimates - MSN
XXII SEC Filings22Nd Century 10-K, 10-Q, 8-K Forms - Stock Titan
MSN Money - MSN
Form 8-KCurrent report - ADVFN
Form SC 13G/AStatement of Beneficial Ownership by Certain Investors: [Amend] - ADVFN
Form S-3Registration statement under Securities Act of 1933 - ADVFN
22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly - ADVFN
22nd Century Group Reports First Quarter 2025 Financial Results - ADVFN
[EFFECT] 22nd Century Group, Inc. SEC Filing - Stock Titan
22nd Century Group (NASDAQ: XXII) registers $250M shelf for multiple securities - Stock Titan
22nd Century Group (NASDAQ: XXII) files $1.84M at‑the‑market shelf - Stock Titan
Does 22nd Century Group Inc outperform in volatile markets - baoquankhu1.vn
XXII News | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative - ADVFN
XXII: 22nd Century Progresses with Low-Nicotine Cigarette Develo - GuruFocus
22nd Century to File New PMTA for 100mm VLN - Tobacco Reporter
22nd Century Group's reduced nicotine bet falls flat with investors (XXII:NASDAQ) - Seeking Alpha
Only FDA-authorized low-nicotine cigarette maker targets 100mm format - Stock Titan
US Market Wrap: What are the future prospects of 22nd Century Group Inc2026 Closing Moves & Reliable Price Breakout Signals - baoquankhu1.vn
Death Cross: Does 22nd Century Group Inc outperform in volatile marketsMarket Volume Summary & Technical Entry and Exit Alerts - baoquankhu1.vn
XXII PE Ratio & Valuation, Is XXII Overvalued - Intellectia AI
XXII Should I Buy - Intellectia AI
22nd Century (XXII) registers $250M shelf; Needham ATM up to $1.84M - Stock Titan
Income Plays: Is ARDT stock a buy or sellTrade Signal Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.25%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):